Inspire Medical Systems, Inc. to Present at the Wells Fargo 2022 Healthcare Conference

Rhea-AI Summary

Inspire Medical Systems, focused on innovative solutions for obstructive sleep apnea, announced their participation at the Wells Fargo 2022 Healthcare Conference on September 8, 2022. The company's management will present at 3:10 p.m. ET at Encore Boston Harbor, Boston, MA. A live webcast of the presentation will be available and can be accessed via Inspire's investor website, along with a replay for two weeks post-event. Inspire offers the first FDA-approved neurostimulation technology targeting moderate to severe obstructive sleep apnea.

News Market Reaction – INSP

+0.96%

+0.96% Session move

In the trading session that priced this news, INSP gained 0.96%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MINNEAPOLIS, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Wells Fargo 2022 Healthcare Conference on Thursday, September 8, 2022 at the Encore Boston Harbor in Boston, MA.

Inspire is scheduled to present at 3:10 p.m. Eastern Time. The presentation will be accessible via a live webcast at:
https://event.webcasts.com/starthere.jsp?ei=1563770&tp_key=f801e95b55&tp_special=8

A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443

FAQ

When is Inspire Medical Systems presenting at the Wells Fargo 2022 Healthcare Conference?

Inspire Medical Systems will present on September 8, 2022, at 3:10 p.m. Eastern Time.

Where will the Wells Fargo 2022 Healthcare Conference take place?

The conference will be held at Encore Boston Harbor in Boston, MA.

How can I access the presentation by Inspire Medical Systems?

The presentation will be available via a live webcast, accessible on Inspire's investor website.

Will there be a replay available for the Inspire presentation?

Yes, a replay of the presentation will be available for two weeks following the event.

What technology does Inspire Medical Systems offer for sleep apnea?

Inspire offers the first FDA-approved neurostimulation technology for the treatment of moderate to severe obstructive sleep apnea.